We deliver end-to-end services from protein sequence through protein expression, purification, crystallization, structural determination, to advanced X-ray based compound screening and innovative de novo protein design for cutting-edge drug discovery. Our automated pipeline serves the diverse needs of pharmaceutical companies, biotechnology firms and academic laboratories engaged in drug development, biological research, and protein engineering.
Gene to protein
Starting from a gene or protein sequence, we cover cloning, expression and purification, resulting in a highly pure protein product.
Protein to structure
We deliver high-quality X-ray data and structures through our automated X-ray crystallography platform and synchrotron access.
Fragment-based screening
We offer small-scale X-ray based fragment screening to assess protein druggability and discover druggable sites, including cryptic pockets.
AI-based protein design
